Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
Will Gene's Supplier Exchange Program and eData skills get him what he wants?
With a no-deal Brexit still a real possibility, Merck continues to prepare for the worst case scenario.
The FDA has accepted TraceLink's blockchain and digital recall projects into its DSCSA Pilot Program.
Sam Herbert walks us through the past 50 years of pharma logistics.
As a leading partner and supplier to the industry, MilliporeSigma continues to strengthen and enhance its supply chain capabilities.
Sitting Down With... David Schoneker, Global Regulatory Director, Strategic Relationships at Colorcon.
Healthcare, fake medicines, and the need for new antibiotics – a round-up from the UK East Africa Health Summit.
Blockchain could be one solution to the saleable returns verification aspect of the US’ Drug Supply Chain Security Act.
Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.
No-deal Brexit poses unique challenges for the development and advanced therapy sectors, not least tight timelines and a limited ability to stockpile.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.